Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study

[1]  F. Clavel-Chapelon,et al.  Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study , 2013, BMC Cancer.

[2]  V. McCormack,et al.  Height, age at menarche and risk of hormone receptor‐positive and ‐negative breast cancer: A cohort study , 2013, International journal of cancer.

[3]  I. Gram,et al.  Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study , 2012, Breast Cancer Research.

[4]  R. E. James,et al.  Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study , 2011, Cancer Prevention Research.

[5]  D. Rimm,et al.  Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Russo,et al.  Pregnancy-Induced Changes in Breast Cancer Risk , 2011, Journal of Mammary Gland Biology and Neoplasia.

[7]  R. Prentice,et al.  Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. , 2011, Journal of the National Cancer Institute.

[8]  Victoria L. Cafourek,et al.  Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.

[9]  J. Palmer,et al.  Oral Contraceptive Use and Estrogen/Progesterone Receptor–Negative Breast Cancer among African American Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[10]  J. Visvader,et al.  Control of mammary stem cell function by steroid hormone signalling , 2010, Nature.

[11]  J. Reis-Filho,et al.  Histological and molecular types of breast cancer: is there a unifying taxonomy? , 2009, Nature Reviews Clinical Oncology.

[12]  J. Reis-Filho,et al.  Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet? , 2009, International journal of surgical pathology.

[13]  M. Pike,et al.  American Journal of Epidemiology Original Contribution Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status the Multiethnic Cohort Study , 2022 .

[14]  P. Porter,et al.  Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer , 2009, Cancer.

[15]  L. Brinton,et al.  Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years , 2009, Cancer Epidemiology Biomarkers & Prevention.

[16]  G. Colditz,et al.  Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer , 2008, Breast Cancer Research.

[17]  B. Strom,et al.  Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First Birth, and Breastfeeding: A Case-Control Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[18]  K. Hede.  Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing. , 2008, Journal of the National Cancer Institute.

[19]  C. Perou,et al.  Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.

[20]  D. Hunter,et al.  Textbook of cancer epidemiology , 2003 .

[21]  C. Sotiriou,et al.  Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures , 2007, Breast Cancer Research.

[22]  T. Byers,et al.  Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non‐Hispanic white women , 2007, International journal of cancer.

[23]  Ian O Ellis,et al.  Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Pike,et al.  Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies , 2006, Breast Cancer Research.

[25]  L. Bernstein,et al.  Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case–control and a case–case comparison , 2006, Breast Cancer Research.

[26]  A. Miller,et al.  Age at menarche in relation to adult height: the EPIC study. , 2005, American journal of epidemiology.

[27]  S. Shapiro,et al.  Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. , 2005, Human reproduction.

[28]  M. García-Closas,et al.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  P. Brown,et al.  The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer , 2004, Breast Cancer Research.

[30]  Mårten Fernö,et al.  Comparison of Immunohistochemical and Biochemical Assay of Steroid Receptors in Primary Breast Cancer Clinical Associations and Reasons for Discrepancies , 2003, Acta oncologica.

[31]  Jo Mitchell,et al.  Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study , 2003, Public Health Nutrition.

[32]  Marilie D. Gammon,et al.  Breast cancers among very young premenopausal women (United States) , 2003, Cancer Causes & Control.

[33]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[34]  A. Miller,et al.  Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2002, Public Health Nutrition.

[35]  L. Ries,et al.  Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups , 2001, Cancer.

[36]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[37]  Ivar Heuch,et al.  Modeling effects of age at and time since delivery on subsequent risk of cancer. , 1999, Epidemiology.

[38]  J. Potter,et al.  The shape of age–incidence curves of female breast cancer by hormone-receptor status , 1999, Cancer Causes & Control.

[39]  Elio Riboli,et al.  The EPIC Project: Rationale and study design , 1997 .

[40]  M Lunn,et al.  Applying Cox regression to competing risks. , 1995, Biometrics.

[41]  D. Apter,et al.  Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood , 1989, International journal of cancer.

[42]  Gretchen L. Gierach,et al.  Epidemiology of triple negative breast cancers. , 2010, Breast disease.

[43]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[44]  A. Ramaioli,et al.  Different clinical impact of estradiol receptor determination according to the analytical method: a study on 1940 breast cancer patients over a period of 16 consecutive years , 2005, Breast Cancer Research and Treatment.

[45]  E Riboli,et al.  The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.

[46]  M. Ocké.  European prospective investigation into cancer and nutrition. Voedingsnavraag in de EPIC studie. , 1996 .